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Abstract
Background
‘Treatment burden’, defined as both the workload and impact of treatment regimens on
function and well-being, has been associated with poor adherence and unfavourable out-
comes. Previous research focused on treatment workload but our understanding of treat-
ment impact is limited. This research aimed to systematically review qualitative research to
identify: 1) what are the treatment generated disruptions experienced by patients across all
chronic conditions and treatments? 2) what strategies do patients employ to minimise these
treatment generated disruptions?
Methods and Findings
The search strategy centred on: treatment burden and qualitative methods. Medline,
CINAHL, Embase, and PsychINFO were searched electronically from inception to Dec
2013. No language limitations were set. Teams of two reviewers independently conducted
paper screening, data extraction, and data analysis. Data were analysed using framework
synthesis informed by Cumulative Complexity Model. Eleven papers reporting data from
294 patients, across a range of conditions, age groups and nationalities were included.
Treatment burdens were experienced as a series of disruptions: biographical disruptions in-
volved loss of freedom and independence, restriction of meaningful activities, negative
emotions and stigma; relational disruptions included strained family and social relationships
and feeling isolated; and, biological disruptions involved physical side-effects. Patients em-
ployed “adaptive treatment work” and “rationalised non-adherence” to minimise treatment
disruptions. Rationalised non-adherence was sanctioned by health professionals at end of
life; at other times it was a “secret-act” which generated feelings of guilt and impacted on
family and clinical relationships.
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Conclusions
Treatments generate negative emotions and physical side effects, strain relationships and
affect identity. Patients minimise these disruptions through additional adaptive work and/or
by non-adherence. This affects physical outcomes and care relationships. There is a need
for clinicians to engage with patients in honest conversations about treatment disruptions
and the ‘adhere-ability’ of recommended regimens. Patient-centred practice requires man-
agement plans which optimise outcomes and minimise disruptions.
Introduction
Living with and managing chronic illness requires hard work as patients seek to cope with,
adapt to and minimise the physical, emotional and biographical impacts of the disease [1, 2].
Navigating services, interacting with health professionals and enacting treatments also creates
work and may generate disruptions to patients’ wellbeing and functioning [3].This has been
termed treatment burden or burden of treatment (BoT).
Conceptual clarity is vital in research and practice. Careful delineation of the causes, compo-
nents and consequences of BoT will enhance attempts to ameliorate it; however, BoT is an
emergent concept which researchers are still working to define. Some have conceptualised
treatment burden as the physiological side-effects (e.g. pain, nausea, dizziness, rash) of medica-
tion, surgery or other therapies [4–6], whilst others have explored BoT from the perspective of
psychosocial consequences [7] and reductions in quality of life [8–12]. Yet others have focussed
on the workload arising from treatment regimens [12], conceptualising treatment burden as
“the self-care practices that patients with chronic disease must perform to enact management
strategies and respond to the demands of healthcare providers and systems”. Treatment work
load is situationally specific; the nature of work and its associated burdens vary in different
countries, partly attributable to differences in the structure and funding of healthcare systems
[3]. The focus on ‘treatment workload’ has usefully led to the application of Normalisation Pro-
cess Theory (NPT) [13] as an analytical framework and the development of a taxonomy of
physical, cognitive and interactional tasks contributing to treatment burden [11]. Further re-
search, using qualitative data, has defined treatment burden as both the workload of treatments
and their impact on “patient functioning and well-being” [3]. Analysing qualitative interviews
(n = 32), across a range of conditions, Eton et al identified the “work patients must do”, “the
strategies and tools which facilitate self-care” and the “factors that exacerbate burden”. Sav,
King [14] conducted a concept analysis of treatment burden in a range of chronic illnesses.
They described the “dynamic and multidimensional” attributes of BoT which consisted of
“both subjective and objective elements” and highlighted the need for a focus beyond workload.
A series of antecedents (e.g. ‘patient characteristics’ and ‘health care systems’) and conse-
quences (e.g. ‘adherence’, ‘resource use’) were also characterised. Whilst the complexity and
fluidity of treatment burden were acknowledged, the conclusions were limited by the paucity of
inductive, qualitative research exploring patient accounts included (n = 1 paper). Further re-
search to describe and classify treatment generated disruptions is required.
In this research we set out to build and extend the body of work on conceptualising treat-
ment burden, across all chronic conditions and treatments, by systematically reviewing empiri-
cal qualitative research to answer the following questions: 1) what are the treatment generated
disruptions experienced by patients across all chronic conditions and treatments? 2) what strat-
egies do patients employ to minimise these treatment generated disruptions?.
A Systematic Review of Treatment Burden
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Table 1 summarises the PICOS rationale.
Methods
Search strategy
Qualitative studies using methods involving direct patient contact, such as interviews and
focus groups, and seeking to understand the patient experience of treatment burden across all
conditions and treatments were sought. Searching and screening were conducted according to
the PRISMA statement (See S1 PRISMA Checklist) [15]. The data bases Medline, CINAHL,
Embase, and PsychINFO were searched electronically. No date limitations were set but “lan-
guage” was restricted to English or Portuguese as there were no resources for translation. We
aimed to identify all papers that used the terms “treatment burden” or “burden of treatment”
in their title or abstract. Given that the systematic identification of qualitative research is prob-
lematic [12, 16] we did not limit our initial search by research method. Rather, identification of
qualitative papers was undertaken during the blinded screening process. Initial searches were
conducted in June 2012 and were updated in April 2014.
Data screening, extraction and analysis
Title, abstract and full paper screening were undertaken independently by three researchers
(AJM; ACG; CA) using a data-extraction proforma designed and piloted by the team. Inclusion
was accepted by concordance; a third party (SD or KH) resolved any disagreements. Duplicates
and any papers not addressing treatment burden at the level of the patient were excluded (e.g.
global economic treatment burden; treatment burden on services). Papers were included only
if they utilised recognised inductive qualitative data collection and analysis methods. Quantita-
tive research, systematic reviews, qualitative syntheses, opinion pieces and papers reporting
qualitative methods but containing no qualitative data (e.g. quotations or thematic frame-
works) were excluded.
Qualitative research is interpretative: data therefore included verbatim quotes and authors’
interpretative comments and were extracted from the findings/results and discussion sections
of papers [11]. Data were analysed using framework synthesis [17, 18] using a coding frame-
work informed by the Cumulative Complexity Model (CCM) [19]. The CCM proposes that the
balance between patient workload (treatment, ‘everyday’ and occupational tasks) and their ca-
pacity to undertake that work influences access and adherence to treatments and consequent
health outcomes. This model was appropriate to our focus on understanding how BoT impacts
on “patient functioning and well-being” [3] and the factors contributing to and shaping these
experiences. We used Shippee et al’s categories (e.g. capacity, workload, adherence etc.) to gen-
erate our framework but did not pre-determine the existence of their proposed inter-
category relationships.
Framework synthesis uses a two staged approach; data extraction and management into
pre-determined categories and then thematic analysis to identify patterns of data within and
Table 1. PICOS table summarising study rationale.
Participants Humans, any age, any condition
Interventions Any treatment
Comparisons Not applicable
Outcomes Treatment burden or Burden of treatment
Study design Qualitative data collection and qualitative analysis of patient perspectives
doi:10.1371/journal.pone.0125457.t001
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between categories [17]. A data management framework, with 4 well defined categories (work-
load, capacity, treatment impact and engagement/adherence) was developed. Data assignment
was undertaken by pairs of researchers (SD/CA: papers 1–4; KH/RO: papers 5–8; SD/AM: pa-
pers 9–11) who coded blind and then met in pairs to discuss and agree categorisation. Finally,
each pair presented their coding to the other and any issues of contention were discussed and
agreed by the whole team.
The second phase of framework synthesis involved thematic analysis of data categorised
within the ‘treatment impact’ category. Two researchers (SD/KH) conducted this analysis sepa-
rately, and then through collaborative discussion, using paper based labelling, fragmenting,
comparing and grouping [20] until a clear taxonomy of the components of treatment impact
were agreed. Finally, relationships between the treatment impacts and those proposed previ-
ously (e.g. capacity, workload and adherence) were identified using constant comparison, team
brainstorming and diagrammatic modelling. Our synthesis generated both second-order (in-
terpretations offered by the original researchers) and third-order constructs (new interpreta-
tions beyond those offered in individual studies) [21].
Our emerging synthesis indicated that people seek healthcare not simply to relieve physical
or emotional symptoms but because those symptoms stop them from doing what they want
(e.g. running or hiking) and being who they want to be (a professional athlete, a member of the
rambling club or an optimistic person). In finalising our synthesis model we therefore called
upon Sen’s capability approach [22] which considers the genuine opportunities (capabilities)
people have to achieve the kind of lives they value: to feel like, do what and be who they want
to be. Treatment burdens were therefore considered to be any treatment generated disruption
in people’s ability to feel, do or be who they wanted to be.
Quality appraisal
Quality appraisal was undertaken using the Critical Appraisal Skills Programme [23] criteria
for qualitative studies. Quality appraisal was independently conducted by two researchers (SD
and KH) and answers compared and discussed. Studies were not, however, excluded on the
basis of quality.
Enhancing analytic credibility through expert patient review
Analytic relevance and credibility was enhanced by inclusion of a lay representative in the
study team (RP). RP brought the following expertise to the team: i) experience of a long-term
condition (stroke); ii) pre-stroke expertise in analysing complex systems and processes iii) lead-
ership of local and national patient organisations. RP critiqued and challenged the emergent
analysis, reflecting on its relevance to his own experience and those of other people with long-
term conditions that he worked with.
Results
Retrieved studies
The initial (April 2012) and updated (April 2014) searches identified a total 1177 papers; after
removal of duplicates, 774 titles and abstracts were screened for relevance; 368 full text articles
were assessed for eligibility; 11 papers which used qualitative methods and analysis and which
presented data on patients’ perspectives of treatment burden were included. Fig 1 presents the
PRISMA flow diagram indicating the inclusion and exclusion of papers at each stage of the
screening process.
A Systematic Review of Treatment Burden
PLOS ONE | DOI:10.1371/journal.pone.0125457 May 29, 2015 4 / 18
Fig 1. PRISMA flow diagram indicating inclusion and exclusion criteria of papers at each stage of screening.
doi:10.1371/journal.pone.0125457.g001
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Study details
Details of included studies are presented in Table 2. A range of qualitative methods were re-
ported: ten used semi-structured interviews, either alone [3, 7, 24–28], with focus groups [29,
30] or with structured measures [8]; one conducted secondary analysis of existing qualitative
data [11]. Included papers addressed a range of chronic conditions across the life-course (aged
8–96 years) including: adults with spasmodic dysphonia [7]; chronic heart failure (CHF) [11];
conditions requiring percutaneous endoscopic gastrostomies (PEG) [8]; chronic kidney disease
(CKD) [24, 28]; people with limited life expectancy due to various conditions [29]; adoles-
cents/young adults with cystic fibrosis (CF) [25] and tuberculosis (TB)[30]; children with Pri-
mary Ciliary Dsykinesia (PCD)[26] and, a range of chronic conditions [3, 14]. The conditions
varied in terms of the severity and impact of disease, the likelihood and immediacy of life
threat, and the invasiveness and criticality of treatments. Studies were undertaken in: the UK
[8, 11, 24, 26], US [3, 7, 25, 29], Nepal [30], Australia [27], and Greece[28]. All of the papers in-
cluded a mix of genders. A variety of qualitative analysis methods were used; all sought to iden-
tify common themes raised by participants.
Table 2. Details of included papers.
Authors Study
reference
Year Country Study design Participants N
(ages)
Condition(s) Studied Stated Focus
Eton et al 3 2012 USA Interviews 32 (26–85
years)
Complex patients with chronic
diseases and polypharmacy
Burden of treatment
from the perspective of
the complex patient
Baylor et al 7 2007 USA Interviews 6 (49–80 years
range)
Spasmodic Dysphonia Psychosocial
consequences of
treatment
Jordan et al 8 2006 UK Interviews
+ structured rating
scale and QoL
measure
20 (24–84
years range)
Long-term percutaneous
endoscopic gastrostomies
Burden of treatment
from a patient
perspective
Gallacher et al 11 2011 UK Secondary analysis
of qualitative
interview
47 (45–88
years range)
Chronic Heart Failure Patients’ experiences of
treatment burden
Johnston and
Noble
24 2012 UK Interviews 9 (74–96 years
range)
Chronic kidney disease Burden of treatment and
impact on treatment
choice
George et al 25 2010 USA Interviews 25 (16–35
years range)
Cystic Fibrosis Barriers and facilitators
to treatment adherence
Schoﬁeld and
Horobin
26 2014 UK Interviews 5.(8–15) Primary Ciliary Dyskinesia Physiotherapy treatment
experiences
Sav et al 27 2013 Australia Interviews 97 (16–83;
mean 57.2)
Chronic conditions Treatment burden
Karamandiou
et al
28 2013 Greece Interviews 7 (32–68 years) End Stage Renal Disease Illness beliefs, treatment
experiences and
adherence
Fried and
Bradley
29 2003 USA Focus groups and
interviews
23 (mean age
of 70 years)
Congestive heart failure,
chronic obstructive pulmonary
disease, or cancer with limited
life expectancy
End-of-Life treatment
decisions
Lewis and
Newell
30 2009 Nepal Interviews and
Focus groups
23 (age not
stated)
Tuberculosis Improving care and
understanding patient
support
doi:10.1371/journal.pone.0125457.t002
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Quality appraisal
Papers were moderate to high quality. The sampling strategy, relationship between researchers
and participants and detailed consideration of ethical issues were the weaker elements of
these papers.
Thematic findings
The synthesis generated eight second-order constructs related to the “negative impacts of treat-
ment on functioning and well-being” which we collated into three third-order constructs “bio-
graphical, relational and biological treatment disruptions”. Table 3 presents these 2nd and 3rd
order constructs and identifies where evidence for each can be found. The synthesis generated
a further two third-order constructs related to the strategies employed by patients to minimise
the disruptions to their valued capabilities: “adaptive treatment work” and “rationalised non-
adherence”. This is also presented graphically in Fig 2.
Biographical disruption. The concept of biographical disruption was first defined by
Bury [2] to explain the disruption to a person’s self-narrative and self-concept that results from
Table 3. Definitions of the 2nd and 3rd order constructs identified, how they inter-relate and where evidence for each can be found.
How treatment burden
was experienced (2nd-
order constructs)
Deﬁnition/description Papers with
data on this
theme
Capability
disruptions
Response to capability
disruptions (3rd-order
constructs)
Physical symptoms and
side effects
Negative impacts of treatments on body
functioning experienced by patients in terms of
treatment side-effects. For instance: pain, nausea,
dizziness, breathlessness, fatigue, infection etc.
This theme also included physical effects which
occurred as a result of treatments or health
service or interactional failures (e.g. pain when
feeding tube blocked due to poor information from
HCP)
3, 7, 8, 11, 24,
26, 27, 28
Biological
disruption
Rationalised mal-adherence And/or
Adaptive work: Managing and
dealing with side effects of
treatment
Negative Emotions Negative affective states such as anxiety, fear,
guilt, frustration which were experienced in
anticipation of, during or as a consequence of
treatments.
7, 8, 11, 24,
25, 27, 28, 29,
30
Biographical
disruption
Rationalised mal-adherence And/or
Adaptive work: Sentimental and
biographical work to reframe self
Stigma and identity
disruption
Negative changes in how patients perceived
themselves or are perceived by others which arise
as a consequence of treatment(s)
7, 8, 24, 25,
26, 27, 28, 29,
30
Living with uncertainty Unpredictable and unstable physical,
psychological and social outcomes affecting
people’s ability to plan and act in the short and/or
long-term
7, 8, 11, 25,
27, 30
Loss of freedom and
independence
Feeling and being constrained by the
requirements of enacting treatments and
monitoring outcomes
7, 8, 24, 25,
26, 28, 29
Loss or restriction of
meaningful activities
Being unable to or restricted in performing valued
occupational, leisure and family roles and
activities by treatment actions or consequences.
7, 8, 11, 25,
28, 29, 30
Feeling isolated and
inadequately supported
Feeling alone whilst trying to cope with treatment
activities or becoming isolated as a consequence
of treatment.
7, 8, 11, 24,
27, 29, 30
Relational
Disruption
Rationalised mal-adherence And/or
Adaptive work: Relational work to
sustain and repair relationships
Experiencing Relationship
strain
Tensions in relationships with family and friends.
These were caused by differing opinions about
need for and quality of treatment adherence,
reminders from families to engage in treatment or
restrictions to the lives of family members
3, 26, 28
doi:10.1371/journal.pone.0125457.t003
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chronic illness [31]. In our review, treatments were similarly identified as a cause of biographi-
cal disruptions impacting on people’s sense of self, negatively affecting their emotions, their
sense of freedom and their ability to engage in meaningful activities. The majority of studies [7,
8, 24–28, 30] highlighted patients’ concerns about the impact treatments had on how they were
seen by others and how they viewed themselves. Stigma was reported when enacting treatments
(e.g. carrying a portable feeding system) or treatment consequences (altered voice following
BOTOX) increased the visibility of otherwise hidden illnesses; when treatments involved others
observing bodily sites, processes or excretions that were intimate or generated repulsion (e.g.
sputum clearance; changing PEG tubes); or, when physical side-effects were embarrassing and
impacted on identity (e.g. weak breathy voice post-botox):
B.W. adjusts her work activities because of how people respond to her when she is in the
breathy voice phase [post-botox]: “When you have the Marilyn Monroe voice, you don’t go
into important situations. They just discredit what you say. Even my friends who are
completely on my side [say] how can we take you seriously? It’s just too funny to listen to Mar-
ilyn Monroe [her identity with the breathy voice].” [7]
Loss of freedom and independence was a recurring theme in six of the reviewed papers [7, 8,
11, 25, 27, 30]. This included the practical loss of freedom conferred by virtue of the time taken
to perform treatments and being physically constrained by technologies such as nebulisers, di-
alysis and feeding machines. Loss of freedom also incorporated the more existential sense of
not being “carefree”.
The need to constantly plan treatments into daily regimes was viewed as loss of spontaneity, par-
ticularly amongst adolescents with CF: a time in the life-course normally associated with increased
freedom and spontaneity. The need to undertake regular treatments and/or monitor treatment out-
comes served as a constant reminder of being ill, even when symptoms had been eradicated.
I used to take detailed notes (of my treatments and outcomes) and I thought later on “this is
excessive”. . . When I was thinking about my voice all the time. . .it turned out to be more of a
pressure thing. [7]
Fig 2. The biographical, relational and biological disruptions generated by treatment burdens and the
strategies of adaptive work and rationalised non-adherence which patients employ to minimise these.
doi:10.1371/journal.pone.0125457.g002
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The need to plan ahead was also linked to the problem of uncertainty [7, 8, 11, 26, 28–30] as
unpredictable treatment outcomes and side-effects created the need for a life lived with contin-
gency plans. Some uncertainty arose from the illness itself, however, some was directly attribut-
able to the treatment. Causes of uncertainty included technological failures (e.g. feeding tubes
becoming blocked), unpredictable responses to medication (botox), lack of easily observable
treatment benefits (CHF, CF, TB), uncertainty about long term side-effects (CHF and botox),
how to administer treatments (PEG feeding) or the purpose or duration of the regime (TB).
Contradictory advice from health staff was also a major cause of uncertainty [28].
Negative emotional consequences were reported in all studies in this review. Emotional re-
sponses were highly variable and related to the individual patient and their social and treat-
ment context. Patients responded with frustration or anger when they perceived treatment
generated burdens to be avoidable e.g. when a lack of staff expertise or knowledge caused pre-
ventable complications or wasted patients’ time or when scheduling of treatments and appoint-
ments was hindered by inflexible services [3, 7, 8, 11, 24, 27, 30]. Anxiety, fear and worry were
highlighted in several studies [3, 7, 8, 27, 28, 30]. People worried about the immediate and
long-term risks of treatment, the future effectiveness of treatments, experiencing pain, losing
employment, being stigmatised by others, the financial implications of treatment and becom-
ing a burden to families. Guilt was experienced in relation to the physical workload or financial
costs of treatment incurred by patients’ families and by patients who were unable to adhere to
treatment recommendations; however, this could be exacerbated or ameliorated by the quality
of relationship between patients and professionals.
“[The doctor] was really funny and outgoing and really nice and that helped a lot getting me back
into clinic. Because I don’t come as often as I should, but I come a lot more than I used to.” [25]
The majority of studies [7, 8, 11, 25–27, 29] identified the reduction or loss of valued activi-
ties as a key element of biographical disruption. People receiving Botox injections weighed up
when to have further injections based on the impact it would have on their valued activities.
For instance one woman, who experienced breathlessness post-Botox, would not have the in-
jection in the summer when she liked to go hiking, whilst another tried to plan the injection to
avoid Christmas and other critical time points. People with CHF also reported avoiding travel-
ling if they had taken diuretics or avoided diuretics if they wanted to travel, and adolescents
with CF made similar decisions modifying their time-consuming treatment regimes so that
they could do the things they wanted.
Holding down a full time job and living life normally—time is a big thing. . .I would rather do
all the things I want to do instead of sit home and do all the things I should and miss out on a
bunch of stuff. . . I am quality over quantity. [25]
Some treatments were not easily modified, for instance people undergoing PEG feeding or
haemodialysis could not stop or reduce their treatments without major consequences. Howev-
er, substantial restrictions to important activities were often deemed acceptable because the
treatment was “life-saving”.
It (PEG) dominates life—it’s in use the greater proportion of the 24 hours. It dominates move-
ment, but we’re happy with it—if it wasn’t for the PEG she wouldn’t be here.’ [8]
Relational disruption. The negative impact of treatments on valued relationships was an-
other common theme in the reviewed studies.
A Systematic Review of Treatment Burden
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Treatments generated feelings of isolation: for instance, people with TB hospitalised far
from family and friends; others had restrictive home-based regimes (PEG feeding, dialysis);
and, children with PCD reported deliberately isolating themselves from friends to avoid the
stigma of expectorating sputum. People requiring highly specialist treatments (e.g. PEG feeding
and Botox) described isolation from appropriate professional support as a consequence of lim-
ited specialists in their community. This resulted in professional uncertainty about appropriate
responses to complications, a lack of guidance about treatments and consequently, some pa-
tients experienced additional physical side-effects, emotional distress, and uncertainty. Poten-
tially avoidable burdens were less well tolerated than those viewed as inherent to the treatment.
When he first had the PEG they (nurses on the ward) pulled the curtains round the bed and
called me back. They told me, ‘You’ll be doing all this tomorrow’. There was just this one short
instruction on the last night in hospital. He came home and nobody came to help us. The dis-
trict nurse had gone sick. And we had the baby in the house as well.My daughter had just
gone into hospital with the afterbirth retained—she was in two weeks. The baby was two
weeks old. There was no help at all. You just had to manage. [8]
Parents reported the strain that could arise in relationships with children [26]. Children
with PCD often had differing opinions from their families on the quality and frequency with
which they engaged in their physiotherapy and nebuliser regimes. Some parents suggested
their children were “lazy” and needed “nagging” which created tension in the relationship and
emotional impacts for both parents and children.
Relationship strain was also evident when time or financial resources spent on treatment
had a negative impact on family leisure activities [26, 28] and some seriously ill people declined
labour intensive treatments for fear of generating excessive family burden [24, 29]:
. . . they were doing dancing and swimming, and we’ve just had to say look guys, I’m sorry,
but we just can’t do anything, so nobody does anything, it’s just all therapy. [28]
My daughter would have to bring me and that would mean [her] taking time off work.[24]
Biological disruption. Treatments also generated biological disruptions in terms of physi-
cal side effects such as pain, nausea, dizziness, breathlessness, fatigue, infection which were re-
ported in over half of the included studies [3, 7, 8, 11, 26–28]. The nature, severity and
frequency of physical side-effects varied substantially across the studies and were related to the
type of treatment received. The PEG feeding study described the greatest range of both type
and severity of symptoms. This may be due to the invasive, restrictive and technically complex
nature of the intervention. However, the study on dialysis (which is also invasive, restrictive
and complex) did not discuss any physical symptoms.
The extent of perceived biological disruption varied from person to person: the same treat-
ment could generate symptoms perceived as intolerable by some and relatively minor by
others:
One participant described intubation saying, “If (the tube] doesn't go in right, they cut you up.
You bleed, you're hurting, so on and so forth. Once it is in you can't talk. Your mouth is dry
and it hurts, even when they take it out. In contrast, another participant, pointing out that he
was not conscious at the time he was intubated, said, "at no time did I know that [the tube]
was going in. . . . I do remember waking up after several days. . . . It did annoy me, but not to
the point of hurting." [29]
A Systematic Review of Treatment Burden
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The severity of physical side-effects did not seem to be directly associated with perceived
burden; rather it was the impact that physical side effects (and indeed other types of burden)
had on people’s ability engage in meaningful activities and on their personal identity that was
most pertinent.
The synthesis highlighted not only how treatment burdens were experienced by patients but
also the strategies patients used to minimise and manage the capability disruptions generated
by treatment. Two third-order constructs were identified: “rationalised non-adherence”, strate-
gies directed at modifying the treatment; and, “adaptive treatment work”, strategies directed at
modifying the self.
Rationalised non-adherence. Rationalised non-adherence, which describes patients’ in-
tentional partial or total non-adherence to treatment recommendations with the aim of mini-
mising biographical, relational or biological disruptions, was reported in the majority of studies
[7, 8, 11, 24–29]. Some patients reported ‘trial and error experiments’ with the timing or dosage
of medications [11, 27]. Patients with CF and PCD [25, 26] substituted boring or difficult phys-
iotherapy with more enjoyable sporting activities which they reframed as “treatments”. They
also admitted using rationalised non-adherence as a strategy for maintaining control and feel-
ing carefree. One woman admitted not getting the next Botox injection in the summer because
she would rather tolerate the voice deficit than become breathless and not be able to go hiking
[7]. Thus, rationalised non-adherence was situational and variable over time depending on the
relevant competing priorities in people’s lives. Most rationalised non-adherence decisions ap-
peared to have been taken by patients without much discussion with Health Care Professionals
(HCPs) and actively concealed from them. When rationalised non-adherence was revealed,
HCPs often expressed disappointment or disapproval and tried to persuade patients to adhere.
This often resulted in patients feeling guilty or not understood. An exception to this was treat-
ments offered at the end of life. In these cases HCPs often helped people to make decisions
about avoiding or withdrawing invasive treatments such as dialysis or assisted ventilation[24,
29]. Clinicians working with people at end of life appeared comfortable with facilitating and
sanctioning ‘rationalised non-adherence decisions’ in order to reduce BoT and maximise quali-
ty of life.
Adaptive treatment work. “Adaptive treatment work” describes the biographical, senti-
mental and relational work that patients and families engaged in as they sought to psychologi-
cally normalise treatments to their lives and their lives to the treatment. Whilst rationalised
non-adherence involved changing or abstaining from treatment, adaptive treatment work in-
volved changing how patients saw themselves or were seen by others.
Patients’ use of strategies to prevent or minimise emotional distress was common through-
out these studies. We refer to this as sentimental work. Some patients sought information and
reassurance from family, on-line reports, or other patients to reduce their emotional distress.
Others used “mental strategies” such as distraction, social comparison and psychological prep-
aration. Adolescents with CF [25] described a process of ‘purposeful forgetting’ to minimise
the emotional impact of treatments whilst people with CKD [28] talked about the need to ‘be
grown up’ about treatments, to keep the ‘desire to be normal at bay’ and develop a ‘healthy
mental attitude’.
Have a healthy mental attitude towards it . . . because if you let it get you down you know it
could quite easily destroy you. . .at least you are still alive and at least there is hope. [28]
Duration of illness seemed to play a part in enabling people to psychologically adjust to and
embed treatments into lifestyles:
A Systematic Review of Treatment Burden
PLOS ONE | DOI:10.1371/journal.pone.0125457 May 29, 2015 11 / 18
I’d recommend the PEG to anyone. You could work with it. I do lots of woodwork (he made
his garden gates) and gardening . . . it shouldn’t affect you . . . it’s not so bad when you’ve
never been well. It must be very hard for people who’ve always been well, but I’ve been ill for
50 years. [8]
People also engaged in biographical work, using reframing to help them maintain a valued
identity. One woman adopted new crafts, allowing her to reframe how she and others saw her
‘bedbound’ lifestyle from “being lazy” to being “productive. Others framed themselves as
“fighters” or “survivors” to help them bear treatment side-effects.
Relational work with family and friends was key to minimising the negative impacts of treat-
ment on patients. This included performing treatments in secret and managing others’ expec-
tations of their abilities.
I don’t think people understand it (the effects of BOTOX). There are really understanding peo-
ple and then others, it’s like ‘well you talk most of the time so why can’t you do that [now]?’
. . . And I’ve tried to explain that the toxin wears off and so that’s a real dilemma. [7]
Fig 2 summarises the findings, indicating how the work of treatment generates biological,
biographical and relational capability disruptions and identifying how these disruptions reduce
patients’ capacity resulting in adaptive work to minimise the disruptions and restore capacity.
Discussion
Strengths and limitations
This review is the first to explore and understand how treatments generate biological, bio-
graphical and relational disruptions in a range of conditions across the life course and illness
trajectory. Moreover, we have been able to identify additional secondary treatment work re-
quired to minimise those disruptions: the combined strategies of adaptation and rationalised
non-adherence. Eleven empirical studies were included, reporting on the perspectives of treat-
ment burden from a total of 294 patients, across a range of age groups and countries. However,
there are a number of limitations to our review. For instance, although we adopted a thorough
and comprehensive search strategy, some relevant studies may not have been identified. We
wanted to focus on gathering emergent data from patients’ own perspectives (rather than more
researcher-led deductive methods) and therefore included only papers which used inductive
qualitative methods suitable for generating depth data. This may have resulted in the exclusion
of potentially relevant data gathered using structured postal, on-line or telephone surveys. Fur-
ther, we restricted our search to English and Portuguese reports as we had no resources for
translation. However, we consider our analysis to have produced an integrated model with suf-
ficient explanatory power to explain the relationships between treatment workload, capacity,
disruptions and adherence. The quality of included studies may affect the validity of our find-
ings: although we undertook quality review of all relevant studies, in the absence of consensus
on the best way to appraise qualitative research [32], and because we wanted to maximise the
reach and comprehensiveness of our findings, we did not exclude on this basis. All aspects of
data extraction, quality appraisal and data analysis were conducted by teams of two research-
ers, with a third party for disagreements. This minimised researcher bias and enhanced analy-
sis. Framework analysis provided a robust theoretical underpinning, using existing models of
treatment burden such as NPT and the cumulative complexity model to inform analytical de-
velopment. We consider this an effective approach but acknowledge that a priori frameworks
risk forcing data inappropriately. We sought to minimise this risk, deliberately moving from
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our initial deductive use of these a priori models (to fractionate and manage the data) into in-
ductive thematic analysis specifically focussed on the perceived impact of treatment burden
and the strategies employed to manage or reduce this. A further strength of this work is the in-
clusion of an expert patient researcher who contributed to the data analysis and writing of the
paper, challenging underdeveloped conceptions and confirming the saliency of the findings to
his own experiences and those of other people with chronic illness that he works with.
Treatment generated disruptions
Over recent years great strides have been taken to clarify conceptual and operational defini-
tions of treatment burden. To date, much of this research has focused on the burden arising
from treatment workload and the impact that workload has on the maintenance of normal ac-
tivity. For instance, Gallacher’s work [11, 12] has highlighted the steps people take to embed
treatments into their daily lives; Eton’s work [3] has considered the impact of patient function-
ing on wellbeing; and Sav’s work [14, 27] has indicated that treatment burden consists of both
objective elements, such as total workload and work complexity, and subjective, patient specif-
ic, elements. By synthesising the evidence across qualitative studies of treatment burden, our
review has been able to expand further on these subjective elements and impacts.
Our findings support the theory proposed by May, Eton [33], by showing that there are im-
portant factors, in addition to the complexity of treatments and the time involved in enacting
them. This means that treatment burden is brought about by both the workload associated
with treatment, and the impacts that workload and treatment complexity have on everyday
life, valued daily activities and patient identity. In this way, we have shown that treatments and
their total workload cause disruptions to a person’s biological, biographical and relational ca-
pacity. Despite finding, in line with previous literature [4–6], that treatments lead to biological
disruptions in the form of physical symptoms and side-effects (such as pain and nausea), our
findings also indicate that it is often not the severity of symptoms that determines how burden-
some treatments are: rather, that the biographical and relational disruptions arising from those
symptoms and side-effects have important impacts for patients. For instance, treatments had
effects on identity, interaction with others and, in many cases, were associated with negative af-
fective states. These affective states include anxiety, fear, anger, and frustration. In some cases
these symptoms were severe and debilitating, further impacting on independence, relationships
with others and ultimately, adherence to treatment regimens. Whilst previous work in this
field has highlighted consequences such as fatigue [8, 27] and frustration [3, 7, 8, 11, 24, 27,
30], the results of this review indicate that the psychological and biographical consequences
may be more far reaching and severe than initially considered. Further research is required to
explore the impact and severity of negative affect and biographical disruption arising from
treatment burden, in order to investigate relationships with quality of life, treatment adherence
and outcome.
Strategies for minimising treatment disruptions: adaptation
This review also adds to the conceptual armoury of treatment burden theory by identifying two
strategies for minimising treatment burden and disruptions: the first of these is adaptation.
Building on previous research [1, 2, 11, 12, 31, 34] we identified three forms of adaptive work:
1. Patients engaged in their own form of Sentimental work to manage the negative affective
states associated with treatment burden. This involved self-soothing behaviours, managing
contact and interactions with friends and family, and developing other strategies to mini-
mise distress. This builds on the work of Corbin and Strauss [1] by extending the concept of
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‘sentimental work’ to work within a patient’s scope, rather than work limited to the remit of
health professionals. Indeed, in a self-management care model where much of the day-to-
day work of illness management is delegated to patients, sentimental work is an important
part of that delegated work.
2. Biographical work was employed by patients to manage changes in their identity brought
about by the burden of treatment. This builds on Bury’s description of illness work [2] by
proposing that, in a healthcare model that has added treatment work to a patient’s total self-
care workload, patients need to engage in biographical work to maintain existing or adapt
to new identities caused by treatment-generated changes.
3. Relational work was carried out to maintain relationships. Earlier burden of treatment re-
search, which was more focussed on the planning, doing and monitoring work of treatment
[3, 11, 12], has discussed the concept of ‘treatment related relational work’. However, this
concentrated on the strategic mobilisation of others to facilitate treatment. Our review ex-
tends this research by addressing the work that patients do to minimise the impact of treat-
ment on valued relationships with self and others. In this way, patients use relational work
to draw on a wider workforce [11, 12, 34] but also to minimise relational disruption and
maximise the work output from that workforce by maintaining optimal, productive and
agreeable relationships.
Strategies for minimising treatment disruptions: rationalised non-
adherence
We identified a second strategy to minimise treatment burden: rationalised non-adherence.
We found that non-adherence was often not an arbitrary act or sign of personal moral failure
as it is sometimes viewed [35, 36] but a rationalised process, used actively and mindfully, as a
way of minimising the burden of treatment. Karamanidou, Weinman [28] discusses a similar
phenomenon in patients undergoing haemodialysis, which they called ‘active non-adherence’.
They attributed this non-adherence to beliefs about the importance (or not) of treatments,
however, we noted non-adherence associated with rationalised decisions based on a desire to
minimise the disruptions associated with treatment. As a result, we have termed this strategy
‘rationalised non-adherence’. Rationalised non-adherence occurred when patients, having ap-
praised the impact of treatment, deliberately decided to cease, modify or reduce their
treatment regime.
We identified two distinct forms of rationalised non-adherence. We found that in studies
which included populations approaching the end of life, non-adherence decisions were fre-
quently sanctioned and supported by clinicians [24, 29]. Indeed, recent policy and practice ini-
tiatives recommend open discussion about end of life treatment decisions and include
directives to support and endorse patients’ decisions, even where these are decisions not to
treat [37–39]. This is in contrast to how non-adherence was discussed in studies exploring less
critical situations [14, 25–28]. We found that rationalised non-adherence at other points in the
illness trajectory or life course was a ‘secret-act’ that must be hidden from others. Such (non)-
treatment decisions were undertaken covertly, without the knowledge, approval or guidance of
professionals. This suggests a lack of concordance between patients’ and clinicians’ perspec-
tives, which according to our data, results in feelings of guilt. It may also affect patient outcome,
because important information is withheld that could affect clinical-reasoning and future treat-
ment recommendations. Adopting some of the principles of the palliative care approach would
facilitate open discussion about the impact of treatment burdens and disruption on adherence
to treatment, thus providing healthcare professionals with an opportunity to consider the
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balance between treatment burden, adaptation and adherence. Links between treatment bur-
den and treatment adherence have also been discussed by May, Montori [40] in their seminal
text on Minimally Disruptive Medicine. They propose that treatment burden can lead to struc-
turally induced non-compliance as a result of increasingly complex and abundant treatment
regimens. In this way, structurally induced non-compliance might be viewed as an overarching
term linking treatment burden with adherence. Our analysis allowed us to explore these links
in greater depth and we have shown that rather than being solely a response to treatment over-
load, non-adherence is often an adaptive and rationalised process employed to minimise
treatment disruption.
Future developments for BoT research
Whilst we have been able to partially explain the link between treatment burden, disruption
and adherence, we have been unable to explore the impact of this non-adherence on relation-
ships with healthcare professionals and family. The data suggest that rationalised non-adher-
ence necessitates further work in the form of concealment, persuasion, and the recruitment of
allies among family and health professionals. However, further empirical research is required
to explore this work in more depth; to consider what this work entails, the severity of its conse-
quences for relationships with others and its impact on outcomes.
In addition to extending our understanding of the burden of treatment by contributing to a
body of work in the field, this review also builds on and adds to recent work on how capacity is
expressed by patients. May, Eton [33] suggest that in order for functional performance (the po-
tential to do the treatment work that needs to be done), patients must mobilise resources from
their social capital and secure the cooperation of others in their formal and informal social net-
work. Doing so is said to allow patients to develop structural resilience. In other words, patients
must adapt in order to absorb, embed and minimise treatment related burden and disruption.
This adaptation or ability to absorb adversity is an expression of capacity. Our findings support
this view by identifying biographical, relational and biological capacity, and outlining a number
of strategies patients use to adapt to disruptions to these components of their capacity. Howev-
er, we note that these strategies involve work that can generate further burdens and disrup-
tions. This may explain why we also identified that in some cases, functional performance is
deliberately sacrificed for quality of life: rationalised non-adherence means ceasing or modify-
ing some of the work of treatment in order to minimise disruption without the additional work
of adaptation. Of course, rationalised non-adherence is still a form of adaptation, albeit one
of circumvention.
Conclusions
This framework synthesis makes a novel contribution to our understanding of treatment bur-
den. Using evidence from the patient’s perspective we found that treatment burden is experi-
enced as biological, biographical and relational disruptions. Patients minimise these
disruptions through adaptation and rationalised non-adherence. Whilst rationalised non-ad-
herence is supported by HCPs at end-of-life; at other times it is a ‘secret-act’ that can generate
guilt, disrupt relationships with HCPs and family, and ultimately reduce health outcomes. Fu-
ture work on burden of treatment should consider both treatment workload and treatment dis-
ruption to fully account for the consequences as well as experiences of treatments. Clinicians
should engage patients in conversations that allow them to acknowledge treatment burden and
discuss adherence difficulties without fear of judgement so that appropriate modifications can
be made to ensure minimally disruptive treatments [33, 40]. Our findings suggest that in order
to be minimally disruptive, treatments not only have to have a low workload (both duration
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and complexity), they also have to cause minimal disruption to people’s biographical, relational
biological capacity.
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